| 10.1364 0.306 (3.12%) | 05-13 13:53 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.16 |
1-year : | 15.37 |
| Resists | First : | 11.27 |
Second : | 13.16 |
| Pivot price | 9.56  |
|||
| Supports | First : | 9.55 |
Second : | 8.5 |
| MAs | MA(5) : | 9.82 |
MA(20) : | 9.86 |
| MA(100) : | 11.51 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 54.1 |
D(3) : | 48.8 |
| RSI | RSI(14): 52.3 |
|||
| 52-week | High : | 17.19 | Low : | 8.5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CARL ] has closed below upper band by 20.8%. Bollinger Bands are 36.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 10.01 - 10.06 | 10.06 - 10.1 |
| Low: | 9.46 - 9.51 | 9.51 - 9.56 |
| Close: | 9.75 - 9.83 | 9.83 - 9.91 |
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.
Mon, 11 May 2026
Number of shareholders of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Sat, 09 May 2026
Wall Street analysts think Carlsmed, Inc. (CARL) could surge 90.77%: Read this before placing a bet - MSN
Thu, 07 May 2026
Here's What Analysts Are Forecasting For Carlsmed, Inc. (NASDAQ:CARL) After Its First-Quarter Results - Yahoo Finance
Thu, 07 May 2026
Carlsmed (CARL) Revenue Growth Of 74.9% Tests Bullish Narratives On Premium Valuation - Sahm
Wed, 06 May 2026
Carlsmed (CARL) Revenue Growth Of 74.9% Tests Bullish Narratives On Premium Valuation - simplywall.st
Tue, 05 May 2026
Carlsmed (CARL) Q1 2026 Earnings Transcript - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 27 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 42.7 (%) |
| Held by Institutions | 37.2 (%) |
| Shares Short | 571 (K) |
| Shares Short P.Month | 629 (K) |
| EPS | -2.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.72 |
| Profit Margin | -58.7 % |
| Operating Margin | -61.5 % |
| Return on Assets (ttm) | -21 % |
| Return on Equity (ttm) | -47.7 % |
| Qtrly Rev. Growth | 61.2 % |
| Gross Profit (p.s.) | 1.39 |
| Sales Per Share | 1.85 |
| EBITDA (p.s.) | -1.12 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -29 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -4.77 |
| PEG Ratio | 0 |
| Price to Book value | 2.71 |
| Price to Sales | 5.44 |
| Price to Cash Flow | -9.5 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|